BLUE BELL, Pa.--(BUSINESS WIRE)--Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today that senior executives of the company will present at the following investor conferences:
BLUE BELL, Pa.--(BUSINESS WIRE)--Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today that senior executives of the company will present at the following investor conferences:
